Does METOPROLOL Cause Agranulocytosis? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Agranulocytosis have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.1% of all adverse event reports for METOPROLOL.
19
Reports of Agranulocytosis with METOPROLOL
0.1%
of all METOPROLOL reports
4
Deaths
13
Hospitalizations
How Dangerous Is Agranulocytosis From METOPROLOL?
Of the 19 reports, 4 (21.1%) resulted in death, 13 (68.4%) required hospitalization, and 5 (26.3%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for METOPROLOL.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which METOPROLOL Alternatives Have Lower Agranulocytosis Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE